Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P207
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Friedman, David J
Young, Kristina
Baird, Jason R
Cottam, Benjamin
Savage, Talicia
Newell, Pippa
Kasiewicz, Melissa
Redmond, William
Curti, Brendan
Crocenzi, Todd
Gough, Michael J
Crittenden, Marka
Article History
First Online: 6 November 2014